HomeBiotechnology

Biotechnology

Galapagos demonstrates regulatory and commercial progress in Q1 2022

Galapagos demonstrates regulatory and commercial progress in Q1 2022

May 5, 2022

Denali Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights

Denali Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights

May 5, 2022

Karuna Therapeutics (KRTX) Posts Narrower-Than-Expected Q1 Loss

Karuna Therapeutics (KRTX) Posts Narrower-Than-Expected Q1 Loss

May 5, 2022

Allogene (ALLO) Q1 Earnings Beat, Pipeline Progresses Well

Allogene (ALLO) Q1 Earnings Beat, Pipeline Progresses Well

May 5, 2022

Thermo Fisher (TMO) End Markets Strong, Margin Under Pressure

Thermo Fisher (TMO) End Markets Strong, Margin Under Pressure

May 5, 2022

Amarin (AMRN) Q1 Earnings & Sales Hurt by Vascepa Generics

Amarin (AMRN) Q1 Earnings & Sales Hurt by Vascepa Generics

May 5, 2022

JAZZ Q1 Earnings Miss, Sales Robust, 2022 Guidance Raised

JAZZ Q1 Earnings Miss, Sales Robust, 2022 Guidance Raised

May 5, 2022

Global Blood (GBT) Q1 Loss Narrower Than Expected, Revenues Lag

Global Blood (GBT) Q1 Loss Narrower Than Expected, Revenues Lag

May 5, 2022

FATE’s Loss Narrower Than Expected in Q1, Pipeline in Focus

FATE’s Loss Narrower Than Expected in Q1, Pipeline in Focus

May 5, 2022

Acadia (ACAD) Q1 Earnings & Revenues Fall Shy of Estimates

Acadia (ACAD) Q1 Earnings & Revenues Fall Shy of Estimates

May 5, 2022

« 1 … 73 74 75 76 77 … 543 »